-
May 5: Causal Inference and Causal Diagrams in Big, Real-World Observational Data and Pragmatic Trials- In Person at ISPOR 2024
-
May 5: Valuing Health: The Generalized Risk Adjusted Cost-Effectiveness (GRACE) Model- In Person at ISPOR 2024
-
Revolutionizing Systematic Reviews: Harnessing the Power of AI
-
The Global Socioeconomic Impact of Rare Diseases: A Call for Action
-
Are Clinical Outcome Assessments Sufficiently Valued?
-
Assessing the Fiscal Burden of Obesity Using a Public Economic Framework
-
June 5-6: Digital Real-World Evidence Generation Approaches in Rare Diseases and Oncology- Virtual
-
Overcoming the Barriers of Open-Source Modeling
-
ISPOR Top 10 HEOR Trends - What Are the Key Themes for 2024-2025?
-
June 26-27: Leveraging Clinical Outcome Assessment (COA) Data to Maximize the Value of New Treatments Beyond Labeling- Virtual
-
The Role of RWE for Devices and Diagnostic Market Access in Europe
-
July 10-11: Causal Machine Learning for Health Economics and Outcomes Research- Virtual
-
IRA Part II: Next 15 For Medicare Drug Price Negotiations in 2025
-
July 24-25: Automated Health Economic Analysis using R Shiny- Virtual
-
Moving Toward Universal Health Coverage in Africa: The Role of HTA
-
September 4-5: Practical Applications of Large Language Models for Real World Evidence Generation and HEOR- Virtual
-
September 18-19: Introduction to Clinical Outcome Assessments (COAs): Selecting, Modifying, or Developing Fit-for-Purpose Measures- Virtual
-
Transferability of Data and Methods to Central and Eastern Europe
-
September 25-26: Understanding Survival Modeling with Application to HTA- Virtual
-
October 2-3: Introduction to Best Practices for Country Adaptations of Economic Models- Virtual